The Program for Advanced Cellular Therapy is excited to announce the promotion of Andrea Pennati, Ph.D., to Director of Research and Development. In this role, Dr. Pennati is responsible for the transition of UW’s pre-clinical …
CRYSTAL A WEINBERGER
Galipeau speaks at Neurosurgery Grand Rounds
Jacques Galipeau, MD, FRCP, PACT Director, recently presented at the Department of Neurosurgery Grand Rounds. The full presentation, “Mesenchymal Stromal Cells for TBI – A first-in-human clinical trial proposal,” can be viewed below:
PACT MANUFACTURING SPECIALIST EARNS CPGP CERTIFICATION
Olga Ganz, one of PACT’s two cell manufacturing specialists, has recently completed the necessary qualifications for the American Society for Quality, Certified Pharmaceutical GMP Professional (CPGP). A CPGP understands the good manufacturing practices (GMP) as …
KIM MCDOWELL PROMOTED TO DIRECTOR OF REGULATORY AFFAIRS FOR PROGRAM FOR ADVANCED CELL THERAPY
Kimberly McDowell, MD, PhD, has been named Director of Regulatory Affairs for the UW Program for Advanced Cell Therapy (PACT). McDowell has served as the program’s associate director of regulatory affairs since 2019, and has …
UW BEGINS NEW CLINICAL TRIAL TO TREAT FATAL BLOOD DISEASES IN CHILDREN, YOUNG ADULTS
The trial is being sponsored by the UW Program for Advanced Cell Therapy (PACT) in partnership with the Department of Pediatrics, Division of Pediatric Hematology, Oncology and Bone Marrow Transplant. The Food and Drug Administration-approved …
Galipeau Chats with UWCCC Emerging Leadership Board
In December 2020, PACT Director Jacques Galipeau took part in Emerging Leadership Board at UW Carbone Cancer Center’s Five Minutes at Five Q&A session about his work in the PACT Program. To view the interview, …
UW Carbone Cancer Center Receives FDA Clearance to Test New Regenerative Medicine Therapy for Radiotherapy-Induced Dry Mouth
The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy. This investigational new drug license, or IND, recently …
UW Program launches first-in-US cell-therapy trial for kidney transplant patients
MADISON, Wis. – For the first time in the United States, a research team will test a personalized cell therapy to treat a common and serious complication facing kidney transplant patients. The UW Program for …
Kim McDowell Hired as Associate Director of Regulatory Affairs
Dr. Kim McDowell has been appointed to oversee the regulatory affairs of the Program for Advanced Cell Therapy (PACT). Her main duties will include crafting and managing investigational new drug (IND) and investigational device exemption …
PACT Names Ross O. Meyers New Director of Cell Manufacturing
The Program for Advanced Cell Therapy (PACT) has selected a new director of cell manufacturing. Ross Meyers will oversee the program’s Good Manufacturing Practice (GMP) lab operations and advanced cell manufacturing as the program works …